Philadose conference highlights psychedelic therapies in Pennsylvania
Featured In The Philadelphia Inquirer
Therapists who work with ketamine say they’re navigating a fast-growing industry to treat patients with severe depression that hasn’t responded to other treatment.
Aubrey Howard, co-founder of Philadose, Sofia Brandstetter, Demeko Freeman and Jess Jones speak during the Philadose conference on psychedelic drugs and how they can be used in therapy. With psychedelics getting legalized in several states, these local experts spoke on psychedelic therapy and what it means for Pennsylvania.